$AMOD
ALPHA MODUS HOLDINGS, INC. Stock $amod

$amod Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000101376223006701 Filed on October 25, 2023

Income Statement

Concept	2023 Q2	2022 Q2
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$491.3K	$339.5K
YoY Change	44.69%	38480.68%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$4.448K	$388.8K
YoY Change	-98.86%	876.2%
Operating Profit	-$541.2K	-$388.8K
YoY Change	39.2%	876.14%
Interest Expense	$209.6K	$3.223M
YoY Change	-93.5%
% of Operating Profit
Other Income/Expense, Net	$327.0K	$3.223M
YoY Change	-89.85%
Pretax Income	-$214.3K	$2.834M
YoY Change	-107.56%	-7215.94%
Income Tax	$169.2K
% Of Pretax Income
Net Earnings	-$383.5K	$2.834M
YoY Change	-113.53%	-7215.4%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.04	$94.48K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$144.6K	$126.5K
YoY Change	14.3%	406.0%
Cash & Equivalents	$144.6K	$126.5K
Short-Term Investments
Other Short-Term Assets	$642.5K	$571.4K
YoY Change	12.45%
Inventory
Prepaid Expenses	$85.00K	$571.4K
Receivables
Other Receivables
Total Short-Term Assets	$787.1K	$697.9K
YoY Change	12.78%	2691.56%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$29.84M	$241.3M
YoY Change	-87.63%
Other Assets		$83.33K
YoY Change		-77.22%
Total Long-Term Assets	$29.84M	$241.4M
YoY Change	-87.64%	65874.33%
TOTAL ASSETS
Total Short-Term Assets	$787.1K	$697.9K
Total Long-Term Assets	$29.84M	$241.4M
Total Assets	$30.63M	$242.1M
YoY Change	-87.35%	61833.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$91.06K	$94.64K
YoY Change	-3.79%	55.4%
Accrued Expenses	$549.3K	$72.44K
YoY Change	658.28%	-75.43%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.752M	$218.3K
YoY Change	1618.89%	-46.21%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$7.289M	$15.86M
YoY Change	-54.04%
Total Long-Term Liabilities	$7.289M	$15.86M
YoY Change	-54.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.752M	$218.3K
Total Long-Term Liabilities	$7.289M	$15.86M
Total Liabilities	$11.04M	$16.08M
YoY Change	-31.33%	3862.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$10.14M	-$15.18M
YoY Change	-33.2%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$10.14M	-$15.18M
YoY Change
Total Liabilities & Shareholders Equity	$30.63M	$242.1M
YoY Change	-87.35%	61833.48%

Cashflow Statement

Concept	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$383.5K	$2.834M
YoY Change	-113.53%	-7215.4%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$646.1K	-$442.9K
YoY Change	45.88%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$1.960K
YoY Change
Cash From Investing Activities	-$1.960K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.390K	0.000
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	-646.1K	-442.9K
Cash From Investing Activities	-1.960K
Cash From Financing Activities	-1.390K	0.000
Net Change In Cash	-649.5K	-442.9K
YoY Change	46.64%	-1871.6%
FREE CASH FLOW
Cash From Operating Activities	-$646.1K	-$442.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity File Number EntityFileNumber	001-40775
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-3386030
	dei	Entity Address Address Line1 EntityAddressAddressLine1	333 East 91st Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10128
	dei	City Area Code CityAreaCode	(917)
	dei	Local Phone Number LocalPhoneNumber	374-2922
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	144592	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	171583	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	557519	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	85001	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	367219	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	787112	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	538802	usd
CY2023Q2	us-gaap	Assets Held In Trust AssetsHeldInTrust	29841332	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	244314622	usd
CY2023Q2	us-gaap	Assets Assets	30628444	usd
CY2022Q4	us-gaap	Assets Assets	244853424	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	91055	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	128835	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	549269	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	68216	usd
CY2023Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	620034	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	467991	usd
CY2023Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2156214	usd
CY2023Q2	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	100000	usd
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	149041	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3751572	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	899083	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	156593	usd
CY2023Q2	inaq	Forward Purchase Agreement Liability Non Current ForwardPurchaseAgreementLiabilityNonCurrent	8035	usd
CY2023Q2	inaq	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	6600000	usd
CY2022Q4	inaq	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	12000000	usd
CY2023Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	681050	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	84890	usd
CY2023Q2	us-gaap	Liabilities Liabilities	11040657	usd
CY2022Q4	us-gaap	Liabilities Liabilities	13140566	usd
CY2023Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	29728906	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	243597590	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10141719	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11885332	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-10141119	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-11884732	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30628444	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	244853424	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	416246	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	339509	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	922572	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	752586	usd
CY2023Q2	us-gaap	Franchisor Costs FranchisorCosts	50000	usd
CY2022Q2	us-gaap	Franchisor Costs FranchisorCosts	49315	usd
	us-gaap	Franchisor Costs FranchisorCosts	100000	usd
	us-gaap	Franchisor Costs FranchisorCosts	98132	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-541246	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-388824	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1172572	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-850718	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	420210	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3036600	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	596160	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6935670	usd
CY2023Q2	inaq	Change In Fair Value Of Forward Purchases Agreement Liability ChangeInFairValueOfForwardPurchasesAgreementLiability	117438	usd
	inaq	Change In Fair Value Of Forward Purchases Agreement Liability ChangeInFairValueOfForwardPurchasesAgreementLiability	78334	usd
CY2023Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	629757	usd
CY2022Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	186500	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	2514748	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	128821	usd
	inaq	Gain On Forgiveness Of Deferred Underwriting Fee Payable GainOnForgivenessOfDeferredUnderwritingFeePayable	273110	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	326985	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3223100	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2270032	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7064491	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-214261	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2834276	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1097460	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6213773	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	169198	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	585450	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-383459	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	2834276	usd
	us-gaap	Net Income Loss NetIncomeLoss	512010	usd
	us-gaap	Net Income Loss NetIncomeLoss	6213773	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-11884732	usd
CY2023Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	3628151	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	100000	usd
CY2023Q1	inaq	Stock Issue During Period Value Initial Value Of Forward Purchased Agreement StockIssueDuringPeriodValueInitialValueOfForwardPurchasedAgreement	86369	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	895469	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-7347481	usd
CY2023Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-253965	usd
CY2023Q2	inaq	Stock Issued During Period Value Excise Tax Payable StockIssuedDuringPeriodValueExciseTaxPayable	2156214	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-383459	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-10141119	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-21394576	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3379497	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-18015079	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	2834276	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-15180803	usd
	us-gaap	Net Income Loss NetIncomeLoss	512010	usd
	us-gaap	Net Income Loss NetIncomeLoss	6213773	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	596160	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6935670	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	2514748	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	128821	usd
	inaq	Gain On Forgiveness Of Deferred Underwriting Fee Payable GainOnForgivenessOfDeferredUnderwritingFeePayable	273110	usd
	inaq	Gain Loss Change In Fair Value Of Forward Purchase Agreement Liability GainLossChangeInFairValueOfForwardPurchaseAgreementLiability	78334	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-156593	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-282218	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-221598	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-37780	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	60307	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	150000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	152043	usd
	inaq	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	49041	usd
	inaq	Increase Decrease In Franchise Tax Payable IncreaseDecreaseInFranchiseTaxPayable	99093	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-936122	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-666433	usd
	inaq	Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes	1446650	usd
	inaq	Cash Withdrawn From Trust Account In Connection With Redemption CashWithdrawnFromTrustAccountInConnectionWithRedemption	215621388	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	80000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	216988038	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	100000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	85000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	215621388	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-215521388	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-85000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	530528	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-751433	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	171583	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	877937	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	702111	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	126504	usd
CY2023Q2	us-gaap	Cash Cash	144592	usd
CY2022Q2	us-gaap	Cash Cash	126504	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	557519	usd
	inaq	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	-5126890	usd
	inaq	Value Of Excise Tax Liability ValueOfExciseTaxLiability	2156214	usd
	inaq	Initial Value Of Forward Purchase Agreement Liability InitialValueOfForwardPurchaseAgreementLiability	83369	usd
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2021-04-20
	inaq	Investments Maximum Maturity Term InvestmentsMaximumMaturityTerm	P185D
CY2023Q2	inaq	Percentage Of Aggregate Fair Market Value Of Asset PercentageOfAggregateFairMarketValueOfAsset	0.80	pure
	inaq	Business Acquisition Percentage Of Voting Interests To Be Acquired On Post Transaction Entity Minimum BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum	0.50	pure
CY2023Q2	inaq	Percentage Of Shares Voted PercentageOfSharesVoted	0.65	pure
CY2023Q2	inaq	Minimum Net Tangible Assets Upon Consummation Of Business Combination MinimumNetTangibleAssetsUponConsummationOfBusinessCombination	5000001	usd
CY2023Q1	inaq	Business Combination Date Of Consummation BusinessCombinationDateOfConsummation	2023-05-07
CY2023Q2	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	80000	usd
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1
CY2023Q2	us-gaap	Deposits Deposits	20000	usd
	inaq	Redemption Exchange RedemptionExchange	1847662	shares
CY2023Q2	us-gaap	Share Price SharePrice	10.05
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.01	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.01	pure
CY2023Q1	inaq	Total Redemption Payment TotalRedemptionPayment	215621387	usd
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2156214	usd
CY2023Q1	inaq	Percentage Of Excise Tax PercentageOfExciseTax	0.01	pure
	us-gaap	Operating Expenses OperatingExpenses	144600	usd
CY2023Q2	inaq	Working Capital Deficit WorkingCapitalDeficit	2964500	usd
	us-gaap	Proceeds From Unsecured Notes Payable ProceedsFromUnsecuredNotesPayable	163000	usd
CY2021Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	157000	usd
CY2021Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	6000	usd
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	557500	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</p>
CY2023Q2	us-gaap	Fair Value Concentration Of Risk Guarantees FairValueConcentrationOfRiskGuarantees	250000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of income and expenses during the reporting period. Making estimates requires management to exercise significant judgment. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liabilities. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
	inaq	Maturity Days MaturityDays	P185Y
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	156593	usd
CY2023Q2	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	169000000	usd
CY2022Q2	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	usd
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	585000	usd
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	0	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	0	usd
	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	the Company effected a 1:1.1162791 stock split of Class B common stock
CY2023Q2	us-gaap	Interest Costs Incurred InterestCostsIncurred	30000	usd
	us-gaap	Interest Costs Incurred InterestCostsIncurred	60000	usd
CY2023Q1	inaq	Waiver Of Underwriting Commissions WaiverOfUnderwritingCommissions	5400000	usd
CY2023Q1	inaq	Deferred Underwriting Commissions DeferredUnderwritingCommissions	8400000	usd
CY2023Q1	inaq	Gain Loss On Forgiveness Of Deferred Underwriting Fees Payable GainLossOnForgivenessOfDeferredUnderwritingFeesPayable	273110	usd
CY2023Q1	inaq	Reminder Of Deferred Underwriting Commissions ReminderOfDeferredUnderwritingCommissions	3000000	usd
CY2023Q2	inaq	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	6600000	usd
CY2022Q4	inaq	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	12000000	usd
CY2023Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2848607	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	inaq	Redemption Payment RedemptionPayment	19208848	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet		usd
CY2022Q4	inaq	Forward Purchase Agreement Liability Non Current ForwardPurchaseAgreementLiabilityNonCurrent		usd
	us-gaap	Business Acquisition Planned Restructuring Activities Description BusinessAcquisitionPlannedRestructuringActivitiesDescription	if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Initial Stockholders or their affiliates, without taking into account any Founder Shares held by the Initial Stockholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
	us-gaap	Class Of Warrant Or Right Expense Or Revenue Recognized ClassOfWarrantOrRightExpenseOrRevenueRecognized	Once the warrants become exercisable, the Company may redeem the outstanding warrants for cash (except as described herein with respect to the Private Placement Warrants): ●in whole and not in part; ●at a price of $0.01 per warrant; ●upon a minimum of 30 days’ prior written notice of redemption; and ●if, and only if, the closing price of Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
CY2023Q2	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	420000	usd
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	596000	usd
CY2022Q2	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	3000000	usd
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	6900000	usd
	us-gaap	Other Expenses OtherExpenses	300000	usd
	inaq	Redemption Exchange RedemptionExchange	1847662	shares
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q2	inaq	Change In Fair Value Of Forward Purchases Agreement Liability ChangeInFairValueOfForwardPurchasesAgreementLiability		usd
	inaq	Change In Fair Value Of Forward Purchases Agreement Liability ChangeInFairValueOfForwardPurchasesAgreementLiability		usd
CY2022Q2	inaq	Gain On Forgiveness Of Deferred Underwriting Fee Payable GainOnForgivenessOfDeferredUnderwritingFeePayable		usd
	inaq	Gain On Forgiveness Of Deferred Underwriting Fee Payable GainOnForgivenessOfDeferredUnderwritingFeePayable		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
	inaq	Gain On Forgiveness Of Deferred Underwriting Fee Payable GainOnForgivenessOfDeferredUnderwritingFeePayable		usd
	inaq	Gain Loss Change In Fair Value Of Forward Purchase Agreement Liability GainLossChangeInFairValueOfForwardPurchaseAgreementLiability		usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
	inaq	Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes CashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes		usd
	inaq	Cash Withdrawn From Trust Account In Connection With Redemption CashWithdrawnFromTrustAccountInConnectionWithRedemption		usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
	inaq	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable		usd
	inaq	Value Of Excise Tax Liability ValueOfExciseTaxLiability		usd
	inaq	Initial Value Of Forward Purchase Agreement Liability InitialValueOfForwardPurchaseAgreementLiability		usd
	us-gaap	Common Stock Voting Rights CommonStockVotingRights
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001862463

Files In Submission

Name	View Source	Status
0001013762-23-006701-index-headers.html	Edgar Link	pending
0001013762-23-006701-index.html	Edgar Link	pending
0001013762-23-006701.txt	Edgar Link	pending
0001013762-23-006701-xbrl.zip	Edgar Link	pending
ex10-10_001.jpg	Edgar Link	pending
ex10-10_002.jpg	Edgar Link	pending
f10q0623ex10-10_insightacq.htm	Edgar Link	pending
f10q0623ex31-1_insightacq.htm	Edgar Link	pending
f10q0623ex31-2_insightacq.htm	Edgar Link	pending
f10q0623ex32-1_insightacq.htm	Edgar Link	pending
f10q0623ex32-2_insightacq.htm	Edgar Link	pending
f10q0623_insightacq.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f10q0623_insightacq_htm.xml	Edgar Link	completed
inaq-20230630.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
inaq-20230630_cal.xml	Edgar Link	unprocessable
inaq-20230630_lab.xml	Edgar Link	unprocessable
inaq-20230630_pre.xml	Edgar Link	unprocessable
inaq-20230630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMOD
ALPHA MODUS HOLDINGS, INC. Stock $amod

2023 Q2 Form 10-Q Financial Statement

#000101376223006701 Filed on October 25, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMOD ALPHA MODUS HOLDINGS, INC. Stock $amod

2023 Q2 Form 10-Q Financial Statement

#000101376223006701 Filed on October 25, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMOD
ALPHA MODUS HOLDINGS, INC. Stock $amod